The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
ID 16507 | Update news 10.07.2025
Decisione di esecuzione (UE) 2022/677 della Commissione del 31 marzo 2022 recante modali...
L’obiettivo è ridurre l’impatto ambientale nei trasporti via mare e su strada e lanciare uno sviluppo competitivo del settore del GNL
Un mese di tempo per acquisire i pareri sul...
ID 21571 | 25.03.2024 / In allegato
Guidance on the Application of the CLP Criteria Guidance to Regulation (EC) No 1272/2008 on clas...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
